Picture Berlin Partner Bionnale 2021 Digital Event 650x80px
Organisation › Details

VelosBio Inc.

VelosBio Inc. is a privately held, US-based, near-term clinical-stage biopharmaceutical company focused on novel cancer targets. The company was founded in 2017 and has an investor syndicate that includes Arix Bioscience, Decheng Capital, Pappas Capital, Sofinnova Ventures, and Takeda Ventures. *


Period Start 2017-01-01 established
  Group Merck (US) (MSD) (Group)
Products Industry antibody-drug conjugate (ADC)
  Industry 2 VLS-101 ADC targeting ROR1 (VelosBio)
Person Person Johnson, David (Dave) (VelosBio 201810 CEO before Acerta Pharma + Roche + Immunex + Millennium + Gloucester)
Region Region San Diego, CA
  Country United States (USA)
  Street 3210 Merryfield Row
  City 92121 San Diego, CA
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Arix Bioscience plc. (10/1/18). "Press Release: Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio". London.
Record changed: 2021-03-26


Picture [iito] Plain Stupid Simple 650x80px

More documents for Merck (US) (MSD) (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture [iito] Back into Ad 650x80px

» top